Leerink-Partners-Deal-Announcement-AN2-Therapeutics | Leerink Partners

Leerink-Partners-Deal-Announcement-AN2-Therapeutics

Published September 20, 2023

AN2 Therapeutics Deal Announcement

More

Featured Intelligence

View additional intelligence

Biopharma M&A Market Update and 2024 Outlook

November 2023

Aware Recovery Care CEO Brian Holzer, MD - Episode 9

November 2023

Featured Research

Biopharma / Emerging Large Biopharma Interest in CNS

November 2023

Partner with Us

to achieve your strategic, capital markets, and investment objectives.

See also:

M&A Advisory

The cornerstone of success is a long-term relationship built on trust

Learn More

Capital Markets

Growth-oriented companies need an experienced partner with demonstrated capital-raising power

Learn More

Equity Research

Investors benefit from our depth of coverage in healthcare sectors

Learn More

Subscribe to receive our thought leadership and marketing updates.